Keow S, Abu-Hilal M. Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study. J Am Acad Dermatol 2024 Jun 8:S0190-9622(24)00891.
PMID: 38857764